The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT 1A receptor

By Jordan S.   Koprivica V.   Chen R.   Tottori K.   Kikuchi T.   Altar C.A.  

European Journal of Pharmacology, Vol. 441, Iss. 3, 2002-04 ,pp. : 137-140

Elsevier

Access to resources Recommend Favorite

Interaction of the novel antipsychotic aripiprazole with 5-HT_1A and 5-HT_2A receptors: functional receptor-binding and in vivo electrophysiological studies

By Stark Arlene   Jordan Shaun   Allers Kelly   Bertekap Robert   Chen Ruoyan   Mistry Kannan Tanaz   Molski Thaddeus   Yocca Frank   Sharp Trevor   Kikuchi Tetsuro   Burris Kevin  

Psychopharmacology, Vol. 190, Iss. 3, 2007-02 ,pp. : 373-382

Springer Publishing Company

Access to resources Recommend Favorite

5-HT 1A receptor agonist properties of the antipsychotic, nemonapride: comparison with bromerguride and clozapine

By Assie M.-B.   Cosi C.   Koek W.  

European Journal of Pharmacology, Vol. 334, Iss. 2, 1997-09 ,pp. : 141-147

Elsevier

Access to resources Recommend Favorite

Effects of WAY 100635 on antipsychotic-induced catalepsy in 5-HT depleted animals: a role for tonic activation of 5-HT 1A receptors

By Prinssen E.P.M.   Koek W.   Kleven M.S.  

European Journal of Pharmacology, Vol. 395, Iss. 2, 2000-04 ,pp. : 143-147

Elsevier

Access to resources Recommend Favorite

F15063, a potential antipsychotic with dopamine D₂/D₃ antagonist, 5-HT_1A agonist and D₄ partial agonist properties: (IV) duration of brain D2-like receptor occupancy and antipsychotic-like activity versus plasma concentration in mice

By Assié Marie-Bernadette   Bardin Laurent   Auclair Agnès   Consul-Denjean Nathalie   Sautel François   Depoortère Ronan   Newman-Tancredi Adrian  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 375, Iss. 4, 2007-06 ,pp. : 241-250

Springer Publishing Company

Access to resources Recommend Favorite